Latest National Cancer Institute Stories
Allegheny Health Network and Johns Hopkins Medicine announced today that they have signed a memorandum of understanding to seek to establish a formal affiliation between Allegheny and the Johns
Blinatumomab, the first BiTE® antibody to be developed for the treatment of cancer, is being investigated by the ECOG-ACRIN Cancer Research Group in its latest trial, E1910. Philadelphia,
Using a nomogram that incorporates age, Gleason score, and prostate-specific antigen (PSA) level at diagnosis, individual risks that a screen-detected prostate cancer has been overdiagnosed can be estimated.
The Annual Report to the Nation on the Status of Cancer, covering the period 1975–2010, showed death rates for lung cancer, which accounts for more than one in four cancer deaths, dropping at a faster pace than in previous years.
A Phase I trial of endoxifen, an active metabolite of the cancer drug tamoxifen, indicates that the experimental drug is safe, with early evidence for anti-tumor activity.
Results from an ECOG-ACRIN Cancer Research Group trial show the benefit of using the combination of docetaxel and ADT as initial treatment. Philadelphia, PA
The Meso Foundation congratulates Congresswomen Betty McCollum and Chellie Pingree for sending a letter to all members of the U.S.
- a meat pie that is usually eaten at Christmas in Quebec